BD Launches Revolutionary Cell Analyzer with Cutting-Edge Technologies

DIAZI, Dhaka - In a move to provide cutting-edge medical technology to researchers worldwide, BD (Becton, Dickinson and Company), a leading global medical technology company, has commenced the commercial launch of its first-ever cell analyzer featuring groundbreaking spectral and real-time cell imaging technologies.

The new instrument is designed to empower scientists in academia and biopharma across a diverse range of applications to uncover deeper insights from cells once invisible in flow cytometry experiments. The BD SpectralFX Technology boasts an impressive ability to analyze up to 50 or more cell characteristics at one time, maintaining optimal resolution and sensitivity for novel biomarker discovery endeavors.

Furthermore, the BD CellView Image Technology enables high-speed fluorescent and label-free imaging of single cells, unraveling precise spatial and morphological insights. This cutting-edge capability allows scientists to pinpoint various details such as the location of viruses or proteins within individual cells, or microscopic interactions between two cells, which can be visually confirmed and analyzed in real-time.

The comprehensive combination of these technologies – first introduced in the BD FACSDiscover S8 Cell Sorter, profiled on the Science journal cover - empowers scientists to generate unprecedented insights per experiment with exceptional speed, depth, and sensitivity. Accompanying software innovations include the latest version of BD FACSChorus Software, which streamlines workflows for both the BD FACSDiscover A8 Cell Analyser and the prestigious cell sorter.

BD's pioneering move is expected to catapult researchers into uncharted territories of cellular analysis, fostering new breakthroughs in medicine and biopharma.